Home | Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma

July 24, 2023

Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma

By The Velsera Clinical and Compliance Team

Thumbnail image for Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma

Extraskeletal myxoid chondrosarcoma (EMC) is an ultra-rare cancer that makes up less than 3% of all soft tissue sarcomas. It most often arises in the soft tissues of the proximal limbs and has a higher incidence in males. Though…